Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial

Summary

The primary objective of this study is to assess the feasibility and acceptability of methods and procedures to be employed in a larger scale decentralized platform adaptive randomized clinical trial in patients with a history of a Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Polymerase Chain Reaction (PCR) positive test and/or medical records from a healthcare provider that coincides with the diagnosis of long-COVID.

Timeline

Start

2024-03-08

Primary completion

2024-06-24

Completion

2024-06-24

Drugs

Indications